Fuse Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 10, 2021 at 03:48 pm EST
Share
Fuse Medical, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 4.25 million compared to USD 5.74 million a year ago. Net loss was USD 0.697036 million compared to net income of USD 0.080484 million a year ago. Basic loss per share from continuing operations was USD 0.01. Diluted loss per share from continuing operations was USD 0.01.
For the nine months, sales was USD 14.36 million compared to USD 14.39 million a year ago. Net loss was USD 1.24 million compared to USD 1.63 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.